Evan Prescott Bailey - 15 Jun 2025 Form 4 Insider Report for Applied Therapeutics, Inc. (APLT)

Role: Chief Medical Officer
Signature: /s/ Leslie D. Funtleyder, as attorney-in-fact
Issuer symbol: APLT
Transactions as of: 15 Jun 2025
Net transactions value: $0
Form type: 4
Filing time: 17 Jun 2025, 16:09:41 UTC
Next filing: 03 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Bailey Evan Prescott	Chief Medical Officer	C/O APPLIED THERAPEUTICS, INC., 545 FIFTH AVENUE, SUITE 1400, NEW YORK	/s/ Leslie D. Funtleyder, as attorney-in-fact	17 Jun 2025	0002071667

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	APLT	Common Stock	Award	$0	+300,000	+55%	$0.000000	841,669	15 Jun 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of compensatory Restricted Stock Units ("RSUs") granted under the Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. Each compensatory RSU represents a contingent right to receive one share of the Issuer's common stock. One fourth (1/4th) of the compensatory RSUs shall vest on June 15, 2026, and the remaining shares subject to the compensatory RSUs shall vest in equal quarterly installments thereafter, subject to the Reporting Person continuing to provide services through each such date.

Content

Consists of compensatory Restricted Stock Units ("RSUs") granted under the Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. Each compensatory RSU represents a contingent right to receive one share of the Issuer's common stock. One fourth (1/4th) of the compensatory RSUs shall vest on June 15, 2026, and the remaining shares subject to the compensatory RSUs shall vest in equal quarterly installments thereafter, subject to the Reporting Person continuing to provide services through each such date.